07 December 2022 : Clinical Research
A Prospective Questionnaire-Based Study to Evaluate Factors Affecting the Decision to Receive COVID-19 Vaccination in 267 Patients with Inflammatory Bowel Disease in Poland
Michał Łodyga


DOI: 10.12659/MSM.938665
Med Sci Monit 2022; 28:e938665
Table 3 Group characteristics – history of IBD.
Variable | Value, n (%) |
---|---|
Group | |
Ulcerative colitis | 107 (40.1) |
Crohn’s disease | 160 (59.9) |
Duration of disease (years) | 11 (6; 15)* |
Medication used | |
Mesalamine | 203 (77.8) |
Sulfasalazine | 21 (8.0) |
Steroids | 62 (23.8) |
Thiopurines | 142 (54.4) |
Methotrexate, cyclosporine | 8 (3.1) |
Infliximab, vedolizumab, adalimumab, ustekinumab | 157 (60.2) |
Tofacitinib | 10 (3.8) |
Other | 1 (0.4) |
Surgical interventions | 91 (34.1) |
Number of operations | 2.00 (1.00; 3.00)* |
IBD – inflammatory bowel disease; * 95% Cl. |